ID   CD40L_RAT               Reviewed;         260 AA.
AC   Q9Z2V2; Q9R254;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-JUN-2002, sequence version 2.
DT   29-MAY-2024, entry version 138.
DE   RecName: Full=CD40 ligand;
DE            Short=CD40-L;
DE   AltName: Full=Tumor necrosis factor ligand superfamily member 5;
DE   AltName: CD_antigen=CD154;
DE   Contains:
DE     RecName: Full=CD40 ligand, membrane form;
DE   Contains:
DE     RecName: Full=CD40 ligand, soluble form {ECO:0000250|UniProtKB:P29965};
DE              Short=sCD40L {ECO:0000250|UniProtKB:P29965};
GN   Name=Cd40lg; Synonyms=Cd40l, Tnfsf5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Splenocyte;
RX   PubMed=10826698; DOI=10.3109/10425170009015609;
RA   Hallett K.M., Oaks M.K.;
RT   "Nucleotide sequence of the rat CD40 ligand.";
RL   DNA Seq. 10:405-406(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=PVG; TISSUE=Spleen;
RA   Daniel K.C., Foss Y., Moussavi A., Macary P., Kemeny D.M., Farzaneh F.,
RA   Gaken J.A.;
RT   "Cloning and sequencing of rat CD40 ligand.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cytokine that acts as a ligand to CD40/TNFRSF5 (By
CC       similarity). Costimulates T-cell proliferation and cytokine production
CC       (By similarity). Its cross-linking on T-cells generates a costimulatory
CC       signal which enhances the production of IL4 and IL10 in conjunction
CC       with the TCR/CD3 ligation and CD28 costimulation (By similarity).
CC       Induces the activation of NF-kappa-B (By similarity). Induces the
CC       activation of kinases MAPK8 and PAK2 in T-cells (By similarity).
CC       Mediates B-cell proliferation in the absence of co-stimulus as well as
CC       IgE production in the presence of IL4 (By similarity). Involved in
CC       immunoglobulin class switching (By similarity).
CC       {ECO:0000250|UniProtKB:P27548, ECO:0000250|UniProtKB:P29965}.
CC   -!- FUNCTION: [CD40 ligand, soluble form]: Acts as a ligand for integrins,
CC       specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40
CC       receptor are required for activation of CD40-CD40LG signaling, which
CC       have cell-type dependent effects, such as B-cell activation, NF-kappa-B
CC       signaling and anti-apoptotic signaling. {ECO:0000250|UniProtKB:P29965}.
CC   -!- SUBUNIT: Homotrimer (By similarity). Interacts with CD28 (By
CC       similarity). CD40 ligand, soluble form: Exists as either a monomer or a
CC       homotrimer (By similarity). Forms a ternary complex between CD40 and
CC       integrins for CD40-CD40LG signaling (By similarity).
CC       {ECO:0000250|UniProtKB:P29965}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P29965};
CC       Single-pass type II membrane protein {ECO:0000250|UniProtKB:P29965}.
CC       Cell surface {ECO:0000250|UniProtKB:P29965}.
CC   -!- SUBCELLULAR LOCATION: [CD40 ligand, soluble form]: Secreted
CC       {ECO:0000250|UniProtKB:P29965}. Note=Release of soluble CD40L from
CC       platelets is partially regulated by GP IIb/IIIa, actin polymerization,
CC       and a matrix metalloproteinases (MMP) inhibitor-sensitive pathway.
CC       {ECO:0000250|UniProtKB:P29965}.
CC   -!- PTM: The soluble form derives from the membrane form by proteolytic
CC       processing. {ECO:0000250|UniProtKB:P29965}.
CC   -!- SIMILARITY: Belongs to the tumor necrosis factor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF116582; AAD22460.1; -; mRNA.
DR   EMBL; AF013985; AAD09323.1; -; mRNA.
DR   RefSeq; NP_445805.1; NM_053353.1.
DR   AlphaFoldDB; Q9Z2V2; -.
DR   SMR; Q9Z2V2; -.
DR   STRING; 10116.ENSRNOP00000001162; -.
DR   GlyCosmos; Q9Z2V2; 1 site, No reported glycans.
DR   GlyGen; Q9Z2V2; 1 site.
DR   iPTMnet; Q9Z2V2; -.
DR   PhosphoSitePlus; Q9Z2V2; -.
DR   PaxDb; 10116-ENSRNOP00000001162; -.
DR   GeneID; 84349; -.
DR   KEGG; rno:84349; -.
DR   AGR; RGD:708418; -.
DR   CTD; 959; -.
DR   RGD; 708418; Cd40lg.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; Q9Z2V2; -.
DR   OrthoDB; 4323672at2759; -.
DR   PhylomeDB; Q9Z2V2; -.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-RNO-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-RNO-5676594; TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway.
DR   PRO; PR:Q9Z2V2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005174; F:CD40 receptor binding; IPI:RGD.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; ISS:UniProtKB.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:InterPro.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISS:UniProtKB.
DR   GO; GO:0023035; P:CD40 signaling pathway; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0097028; P:dendritic cell differentiation; IMP:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0045190; P:isotype switching; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0030168; P:platelet activation; ISS:UniProtKB.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:RGD.
DR   GO; GO:2001200; P:positive regulation of dendritic cell differentiation; IDA:RGD.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:RGD.
DR   GO; GO:0002839; P:positive regulation of immune response to tumor cell; IDA:RGD.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IDA:RGD.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IDA:RGD.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; IDA:RGD.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; IDA:RGD.
DR   GO; GO:0002637; P:regulation of immunoglobulin production; ISO:RGD.
DR   GO; GO:0033590; P:response to cobalamin; IEP:RGD.
DR   GO; GO:1901652; P:response to peptide; IEP:RGD.
DR   CDD; cd00184; TNF; 1.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR003263; CD40L.
DR   InterPro; IPR021184; TNF_CS.
DR   InterPro; IPR006052; TNF_dom.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR11471:SF5; CD40 LIGAND; 1.
DR   PANTHER; PTHR11471; TUMOR NECROSIS FACTOR FAMILY MEMBER; 1.
DR   Pfam; PF00229; TNF; 1.
DR   PIRSF; PIRSF016527; TNF_5; 1.
DR   PRINTS; PR01702; CD40LIGAND.
DR   SMART; SM00207; TNF; 1.
DR   SUPFAM; SSF49842; TNF-like; 1.
DR   PROSITE; PS00251; THD_1; 1.
DR   PROSITE; PS50049; THD_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cytokine; Disulfide bond; Glycoprotein; Membrane;
KW   Reference proteome; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..260
FT                   /note="CD40 ligand, membrane form"
FT                   /id="PRO_0000034494"
FT   CHAIN           112..260
FT                   /note="CD40 ligand, soluble form"
FT                   /evidence="ECO:0000250|UniProtKB:P29965"
FT                   /id="PRO_0000034495"
FT   TOPO_DOM        1..22
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        23..43
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        44..260
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          121..260
FT                   /note="THD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01387"
FT   SITE            111..112
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        177..217
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01387"
FT   CONFLICT        41
FT                   /note="P -> L (in Ref. 1; AAD09323)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="R -> K (in Ref. 1; AAD09323)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        255
FT                   /note="I -> F (in Ref. 1; AAD09323)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   260 AA;  29260 MW;  B3D3757DE60DB73A CRC64;
     MIETYSQPSP RSVATGLPAS MKIFMYLLTV FLITQMIGSV PFAVYLHRRL DKVEEEASLH
     EDFVFVKKLK RCNKGEGSLS LLNCEEMRRQ FEDLVKDISL NKEEKKEKSF EMQRGDEDPQ
     IAAHVVSEAN SNAASVLQWA KKGYYTMKSN LVVLENGRQL TVKREGLYYV YTQVTFCSNR
     EPLSQRPFIV SLWLKPSSGS ERILLRAANT HSSSKLCEQQ SIHLGGVFEL QAGASVFVNV
     TEASQVIHGI GFSSIGLLKL
//
